Jefferies Group LLC Cytokinetics Inc Transaction History

Jefferies Group LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	BUY	$33.93 - $48.92 $663,331 - $956,386	19,550 Added 195.5%	29,550 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $1 Million - $1.45 Million	29,550 New	29,550 $1.16 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $297,400 - $460,000	-10,000 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$34.35 - $46.38 $2.15 Million - $2.9 Million	-62,500 Reduced 86.21%	10,000 $455,000
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $2.15 Million - $2.9 Million	-62,500 Reduced 86.21%	10,000 $456,000
Q3 2021 Sep 21, 2023	BUY	$18.54 - $35.74 $1.34 Million - $2.59 Million	72,500 New	72,500 $2.59 Million
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $1.34 Million - $2.59 Million	72,500 New	72,500 $2.59 Million
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $742,002 - $1.39 Million	-48,624 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $1 Million - $1.41 Million	48,624 New	48,624 $1.05 Million
Q1 2019 May 15, 2019	SELL	$5.95 - $10.19 $95,378 - $163,345	-16,030 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $28,545 - $44,870	4,830 Added 43.13%	16,030 $101,000
Q3 2018 Nov 14, 2018	BUY	$6.4 - $9.85 $71,680 - $110,320	11,200 New	11,200 $110,000

406

126M

3.29M

2.01M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.93B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.